Design and synthesis of disubstituted (4-piperidinyl)-piperazine derivatives as potent acetyl-CoA carboxylase inhibitors.
Acetyl-CoA carboxylases (ACCs), the rate limiting enzymes in de novo lipid synthesis, play important roles in modulating energy metabolism. The inhibition of ACC has demonstrated promising therapeutic potential for treating obesity and type 2 diabetes mellitus in transgenic mice and preclinical animal models. We describe herein the structure-based design and synthesis of a novel series of disubstituted (4-piperidinyl)-piperazine derivatives as ACC inhibitors. Our structure-based approach led to the discovery of the indole derivatives 13i and 13j, which exhibited potent in vitro ACC inhibitory activity.
Taisho Pharmaceutical Co., Ltd, Kita-ku, Saitama-shi, Saitama, Japan. tomomichi.chonan@po.rd.taisho.co.jp
Tomomichi
T
Chonan
Hiroaki
H
Tanaka
Daisuke
D
Yamamoto
Miyoko
M
Yashiro
Takahiro
T
Oi
Daisuke
D
Wakasugi
Ayumi
A
Ohoka-Sugita
Fusayo
F
Io
Hiroko
H
Koretsune
Akira
A
Hiratate
D000103:Acetyl-CoA Carboxylase / Q000037:antagonists & inhibitors*; D018360:Crystallography, X-Ray; D004305:Dose-Response Relationship, Drug; D015195:Drug Design; D004791:Enzyme Inhibitors / Q000138:chemical synthesis / Q000737:chemistry / Q000494:pharmacology*; D008958:Models, Molecular; D015394:Molecular Structure; D010879:Piperazines / Q000138:chemical synthesis / Q000737:chemistry / Q000494:pharmacology*; D010880:Piperidines / Q000138:chemical synthesis / Q000737:chemistry / Q000494:pharmacology*; D013237:Stereoisomerism; D013329:Structure-Activity Relationship
D004791:Enzyme Inhibitors; D010879:Piperazines; D010880:Piperidines; D000103:Acetyl-CoA Carboxylase